United Kingdom (UK)
Recombinant monoclonal antibody to NMDAR. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma N416/40.
UniProt Accession Number of Target Protein: A2AIR5
Alternative Name(s) of Target: Glun3A/NR3A; GluN3A; Ionotropic glutamate receptor 3A; N-methyl-D-aspartate receptor subtype 3A; Glutamate receptor chi-1; NMDAR3A; NMDAR-L; NMDAR-L1; NR3A; Grin3A; KIAA1973; N416/40.1.2
Immunogen: The original antibody was generated by immunizing Balb/c mice with fusion protein amino acids 58-87 or 152-176 (extracellular N-terminus) of mouse GluN3A.
Specificity: This antibody is specific for subunit GluN3A of mouse NMDAR and cross-reacts with rat NMDAR.
Application Notes: This antibody can be used for IB, ICC, and IHC (RRID: AB_2877604). Independently, it was used for WB (Hotovec, 2023; DOI: 20.500.11956/184763).
Antibody first published in:
Hotovec. NMDA receptors outside CNS and their subunit composition Karlova University. 2023. PMID:
Note on publication:
The original publication investigates the presence and subunit composition of N-Methyl-D-Aspartate receptors (NMDARs) outside the central nervous system, particularly in the gastrointestinal tract, using subunit-specific modulators and attempted immunolabeling with monoclonal antibodies.